Loading...
Agenda 04/24/2018 Item #16C304/24/2018 EXECUTIVE SUMMARY Recommendation to approve the First Amendment to Agreement #17-7156 and authorize a Sole- Source Waiver for a period of three years for the purchase of Bioxide Plus 71, Aktivox and VX456 from Evoqua Water Technologies LLC for use by the Public Utilities Department Wastewater Division. OBJECTIVE: To ensure the Wastewater Division remains in regulatory compliance (62 -604 F.A.C.), minimizes odors consistent with the good neighbor policy, and meets demand with sustained reliability by utilizing Evoqua Water Technologies LLC’s (Evoqua) advanced products in the wastewater collection system and the water reclamation facilities. CONSIDERATIONS: The Collier County Wastewater Division operates more than 60 odor control systems. The technologies that Evoqua provides enable the Wastewater Division to reduce dissolved sulfides to minimize the impact on the odor control systems located in the more than 850 lift stations and two water reclamation facilities. On May 23, 2017, the Board of County Commissioners (Board) approved agenda item 16C3 for the sole source purchases of Evoqua’s Bioxide Plus 71, Aktivox and VX456 for a period of one year in the estimated amount of $500,000. On January 9, 2018, the Board approved agenda item 16C4 for an increase of $250,000 to the purchase order for Bioxide Plus 71, Aktivox and VX456 from Evoqua Water Technologies LLC for use by the Public Utilities Department Wastewater Division. The current agreement with Evoqua expires on May 31, 2018. The Public Utilities Department requests sole-source authorization for three years to maintain uninterrupted and continued use of Evoqua’s odor control products. In July 2017, staff conducted an internal study of Collier County’s wastewater treatment and chemical usage and surveyed local sister utilities of Manatee County, Loxahatchee, City of Tampa, Fort Pierce, Boca Raton and Lee County to obtain an understanding of the technologies and chemicals used in the collection and treatment of wastewater. Collier County, Lee County and Manatee County are similar in size, demographics and topography. This review and analysis did not provide a conclusive determination of "the best" odor control technology. Rather, it supported the contention that the existing conditions, treatment objectives and economic restraints must be considered in selection and design of any odor control strategy. These municipalities continue to utilize Evoqua products and services. Collier County has a prohibition on using any hazardous rated materials in the collections system, limiting the technology choices available to control odorous and corrosion issues. The County ensures that technologies used will not affect natural resources, public health and/or personal safety. Some odor control chemicals such as bleach and chlorine can be volatile and create containment concerns. Use of these chemicals in the collections system can create biological and delivery issues. Bioxide Plus 71 is a non-toxic and safe product that is fed into the piping system be tween pump stations to minimize dissolved sulfides created in the collections system. Reduction of dissolved sulfide assists with minimizing higher levels of hydrogen sulfides to a manageable level for the odor control systems. Aktivox and VX456 are utilized at the water reclamation facilities to provide an immediate impact to reduce dissolved sulfides. The use of these technologies also assists with other odors associated with sewage processing. 16.C.3 Packet Pg. 807 04/24/2018 These products provide the following additional benefits and advantages: Reduces fats, oils and grease in the piping and pump station wet wells. This results in labor and equipment cost savings by reducing the frequency of cleaning. Allows the continued use of the existing, smaller odor control systems. Reduces the potential of higher strength gasses that may affect the health and safety of plant employees and residents who reside near the plants. Staff is requesting the continued purchase of Bioxide Plus 71, Aktivox and VX456 from Evoqua pursuant to the Procurement Ordinance, Section V.C1, Section 9, as the sole-source provider for these patented products that have proven effective for the intended purpose. The Bioxide Plus 71, Aktivox and VX456 from Evoqua constitute an implied license to practice the processes described in the United States Patent numbers 7,779,224B2,7,799,215B2 and US8,968,646B2. Bioxide Plus 71, Aktivox and VX456 are registered trademarks of Evoqua Water Technologies LLC. The proposed First Amendment to Agreement # 17-7156 includes an increase in the unit price of these products that will become effective on June 1, 2018 and lock in through May 31, 2021. FISCAL IMPACT: Funds are available in the Collier County Water-Sewer District Operating Fund (408) and the Wastewater User Fee Fund (414). The actual amount to be expended will depend on the demands on the wastewater system. The estimated cost will be approximately $750,000 - $900,000 per year. GROWTH MANAGEMENT IMPACT: This project meets current Growth Management Plan standards to insure the viability of public facilities. LEGAL CONSIDERATIONS: This item is approved as to form and legality, and requires majority vote for Board approval. -SRT RECOMMENDATION: That the Board of County Commissioners authorizes the Sole-Source Waiver for a period of three years for the purchase of Bioxide Plus 71, Aktivox and VX456 from Evoqua Water Technologies LLC for use by the Public Utilities Department Wastewater Division and to authorize the Chairman to sign the attached proposed First Amendment to Agreement #17-7156. Prepared by: Beth Johnssen, Wastewater Division Director Steve Messner, Water Division Director ATTACHMENT(S) 1. 17-7156 Evoqua_Amend 1_Rev_VendSign (PDF) 2. Waiver Request 330 - Evoqua (PDF) 3. 17-7156 Evoqua_Contract_FullExec (PDF) 16.C.3 Packet Pg. 808 04/24/2018 COLLIER COUNTY Board of County Commissioners Item Number: 16.C.3 Doc ID: 5194 Item Summary: Recommendation to approve the First Amendment to Agreement #17-7156 and authorize a Sole-Source Waiver for a period of three years for the purchase of Bioxide Plus 71, Aktivox and VX456 from Evoqua Water Technologies LLC for use by the Public Utilities Department Wastewater Division. Meeting Date: 04/24/2018 Prepared by: Title: Operations Analyst – Public Utilities Department Name: Susan Jacobs 03/22/2018 1:18 PM Submitted by: Title: Department Head - Public Utilities – Public Utilities Department Name: George Yilmaz 03/22/2018 1:18 PM Approved By: Review: Procurement Services Opal Vann Level 1 Purchasing Gatekeeper Completed 03/22/2018 3:50 PM Procurement Services Ted Coyman Additional Reviewer Completed 03/27/2018 9:45 AM Public Utilities Operations Support Joseph Bellone Additional Reviewer Completed 03/27/2018 12:56 PM Solid and Hazardous Waste Sarah Hamilton Additional Reviewer Completed 03/29/2018 9:23 AM Procurement Services Heather Bustos Additional Reviewer Skipped 03/29/2018 1:28 PM Public Utilities Department Heather Bustos Level 1 Division Reviewer Completed 03/29/2018 1:30 PM Public Utilities Department George Yilmaz Level 2 Division Administrator Review Completed 03/30/2018 10:44 PM County Attorney's Office Scott Teach Level 2 Attorney Review Completed 04/02/2018 8:37 AM County Attorney's Office Jeffrey A. Klatzkow Level 3 County Attorney's Office Review Completed 04/02/2018 10:04 AM Office of Management and Budget Valerie Fleming Level 3 OMB Gatekeeper Review Completed 04/05/2018 4:57 PM Budget and Management Office Ed Finn Additional Reviewer Completed 04/10/2018 8:34 PM Office of Management and Budget Susan Usher Additional Reviewer Completed 04/14/2018 12:17 PM County Manager's Office Nick Casalanguida Level 4 County Manager Review Completed 04/17/2018 12:16 PM Board of County Commissioners MaryJo Brock Meeting Pending 04/24/2018 9:00 AM 16.C.3 Packet Pg. 809 16.C.3.aPacket Pg. 810Attachment: 17-7156 Evoqua_Amend 1_Rev_VendSign (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.aPacket Pg. 811Attachment: 17-7156 Evoqua_Amend 1_Rev_VendSign (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.aPacket Pg. 812Attachment: 17-7156 Evoqua_Amend 1_Rev_VendSign (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.aPacket Pg. 813Attachment: 17-7156 Evoqua_Amend 1_Rev_VendSign (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 814 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 815 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 816 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 817 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 818 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 819 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 820 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 821 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 822 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.b Packet Pg. 823 Attachment: Waiver Request 330 - Evoqua (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 824Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 825Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 826Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 827Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 828Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 829Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 830Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 831Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 832Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 833Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 834Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua) 16.C.3.cPacket Pg. 835Attachment: 17-7156 Evoqua_Contract_FullExec (5194 : First Amendment to Agreement #17-7156 for Evoqua)